34 results
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
of technology (whether or not embodied in any tangible form and including all tangible embodiments of the foregoing), and (vi) social media accounts … , social media identifiers, internet domain name registrations.
“Intellectual Property Assignment Agreement” means the assignment agreement assigning
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
experienced an increase in phishing and social engineering attacks from third parties, including in connection with the recent COVID-19 pandemic. Also, due
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
. et seq. (“HIPAA”); Section 1128B(b) of the Social Security Act, as amended; 42 U.S.C. § 1320a-7b (Criminal Penalties Involving Medicare or State … Health Care Programs), commonly referred to as the “Federal Anti-Kickback Statute”; § 1877 of the Social Security Act, as amended; 42 U.S.C. § 1395nn
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
, medical or healthcare products, items and services, including, without limitation, 45 C.F.R. et seq. (“HIPAA”); Section 1128B(b) of the Social Security Act … -Kickback Statute”; § 1877 of the Social Security Act, as amended; 42 U.S.C. § 1395nn (Limitation on Certain Physician Referrals), commonly referred
PRE 14A
2ugs63 jq
14 Apr 23
Preliminary proxy
4:11pm
424B5
xvd5fk07 jybpxcj83dn
24 May 22
Prospectus supplement for primary offering
4:32pm
S-3
dvnqvaa83r6k8rmc
16 May 22
Shelf registration
4:49pm
DEF 14A
klvjf7 5vj6htve13si
26 Apr 22
Definitive proxy
4:16pm
10-K
q57ickv
29 Mar 22
Annual report
5:09pm
424B4
53euhxo4t650 iw
10 Sep 21
Prospectus supplement with pricing info
4:01pm